Key result
In post-MI patients without atrial fibrillation, every point in the CHA2DS2-VASc score was associated with a 41% increase in stroke risk and a 23% increase in mortality (P<0.001).
Why the study?
Does the CHA2DS2-VASc score predict ischemic stroke and death in patients after acute myocardial infarction without atrial fibrillation?
Cohort (n=2,647)
No
Does the CHA2DS2-VASc score predict ischemic stroke and death in patients after acute myocardial infarction without atrial fibrillation?
Effect estimate: 41% increase in stroke risk and 23% increase in mortality per point
p-value: p=<0.001
The CHA2DS2-VASc score can effectively stratify the risk of ischemic stroke and death in post-MI patients without atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
CHA2DS2-VASc may stratify stroke and mortality risk post-MI without AF; extends validation but remains hypothesis-generating pending prospective trials.
Podolecki et al. (2015) conducted a cohort in Acute myocardial infarction without atrial fibrillation (n=2,647). CHA2DS2-VASc score vs. Low-risk score (1 point) was evaluated on Ischemic stroke and death (41% increase in stroke risk and 23% increase in mortality per point, p=<0.001). In post-MI patients without atrial fibrillation, every point in the CHA2DS2-VASc score was associated with a 41% increase in stroke risk and a 23% increase in mortality (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: